ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF
Antibodies directed to the antigen TNFα and uses of such antibodies. In particular, fully human monoclonal antibodies directed to the antigen TNFα. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JASPAL, S. KANG ORIT FOORD JOHN, S. BABCOOK CRAIG PIGOTT MARY HAAK-FRENDSCHO SCOTT KLAKAMP LARRY GREEN MEINA, L. LIANG PALANISWAMI RATHANASWAMI RAFFAELLA FAGGIONI XIAO FENG ROZANNE LEE JANE, SU QIAOJUAN KATHY MANCHULENCHO GIORGIO SENALDI |
| description | Antibodies directed to the antigen TNFα and uses of such antibodies. In particular, fully human monoclonal antibodies directed to the antigen TNFα. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2003298816A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2003298816A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2003298816A13</originalsourceid><addsrcrecordid>eNrjZLB19AvxdPJ38XQNVnDxDHJ1DnF1UQjxVwgJ9fUPUvBzdQ7yD_YMVnBzdA4B8h39XBRCg4FKQzxcg1z93XgYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBgbGRpYWFoZmjoTFxqgDQMyqn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF</title><source>esp@cenet</source><creator>JASPAL, S. KANG ; ORIT FOORD ; JOHN, S. BABCOOK ; CRAIG PIGOTT ; MARY HAAK-FRENDSCHO ; SCOTT KLAKAMP ; LARRY GREEN ; MEINA, L. LIANG ; PALANISWAMI RATHANASWAMI ; RAFFAELLA FAGGIONI ; XIAO FENG ; ROZANNE LEE ; JANE, SU QIAOJUAN ; KATHY MANCHULENCHO ; GIORGIO SENALDI</creator><creatorcontrib>JASPAL, S. KANG ; ORIT FOORD ; JOHN, S. BABCOOK ; CRAIG PIGOTT ; MARY HAAK-FRENDSCHO ; SCOTT KLAKAMP ; LARRY GREEN ; MEINA, L. LIANG ; PALANISWAMI RATHANASWAMI ; RAFFAELLA FAGGIONI ; XIAO FENG ; ROZANNE LEE ; JANE, SU QIAOJUAN ; KATHY MANCHULENCHO ; GIORGIO SENALDI</creatorcontrib><description>Antibodies directed to the antigen TNFα and uses of such antibodies. In particular, fully human monoclonal antibodies directed to the antigen TNFα. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040623&DB=EPODOC&CC=AU&NR=2003298816A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040623&DB=EPODOC&CC=AU&NR=2003298816A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JASPAL, S. KANG</creatorcontrib><creatorcontrib>ORIT FOORD</creatorcontrib><creatorcontrib>JOHN, S. BABCOOK</creatorcontrib><creatorcontrib>CRAIG PIGOTT</creatorcontrib><creatorcontrib>MARY HAAK-FRENDSCHO</creatorcontrib><creatorcontrib>SCOTT KLAKAMP</creatorcontrib><creatorcontrib>LARRY GREEN</creatorcontrib><creatorcontrib>MEINA, L. LIANG</creatorcontrib><creatorcontrib>PALANISWAMI RATHANASWAMI</creatorcontrib><creatorcontrib>RAFFAELLA FAGGIONI</creatorcontrib><creatorcontrib>XIAO FENG</creatorcontrib><creatorcontrib>ROZANNE LEE</creatorcontrib><creatorcontrib>JANE, SU QIAOJUAN</creatorcontrib><creatorcontrib>KATHY MANCHULENCHO</creatorcontrib><creatorcontrib>GIORGIO SENALDI</creatorcontrib><title>ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF</title><description>Antibodies directed to the antigen TNFα and uses of such antibodies. In particular, fully human monoclonal antibodies directed to the antigen TNFα. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB19AvxdPJ38XQNVnDxDHJ1DnF1UQjxVwgJ9fUPUvBzdQ7yD_YMVnBzdA4B8h39XBRCg4FKQzxcg1z93XgYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBgbGRpYWFoZmjoTFxqgDQMyqn</recordid><startdate>20040623</startdate><enddate>20040623</enddate><creator>JASPAL, S. KANG</creator><creator>ORIT FOORD</creator><creator>JOHN, S. BABCOOK</creator><creator>CRAIG PIGOTT</creator><creator>MARY HAAK-FRENDSCHO</creator><creator>SCOTT KLAKAMP</creator><creator>LARRY GREEN</creator><creator>MEINA, L. LIANG</creator><creator>PALANISWAMI RATHANASWAMI</creator><creator>RAFFAELLA FAGGIONI</creator><creator>XIAO FENG</creator><creator>ROZANNE LEE</creator><creator>JANE, SU QIAOJUAN</creator><creator>KATHY MANCHULENCHO</creator><creator>GIORGIO SENALDI</creator><scope>EVB</scope></search><sort><creationdate>20040623</creationdate><title>ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF</title><author>JASPAL, S. KANG ; ORIT FOORD ; JOHN, S. BABCOOK ; CRAIG PIGOTT ; MARY HAAK-FRENDSCHO ; SCOTT KLAKAMP ; LARRY GREEN ; MEINA, L. LIANG ; PALANISWAMI RATHANASWAMI ; RAFFAELLA FAGGIONI ; XIAO FENG ; ROZANNE LEE ; JANE, SU QIAOJUAN ; KATHY MANCHULENCHO ; GIORGIO SENALDI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2003298816A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>JASPAL, S. KANG</creatorcontrib><creatorcontrib>ORIT FOORD</creatorcontrib><creatorcontrib>JOHN, S. BABCOOK</creatorcontrib><creatorcontrib>CRAIG PIGOTT</creatorcontrib><creatorcontrib>MARY HAAK-FRENDSCHO</creatorcontrib><creatorcontrib>SCOTT KLAKAMP</creatorcontrib><creatorcontrib>LARRY GREEN</creatorcontrib><creatorcontrib>MEINA, L. LIANG</creatorcontrib><creatorcontrib>PALANISWAMI RATHANASWAMI</creatorcontrib><creatorcontrib>RAFFAELLA FAGGIONI</creatorcontrib><creatorcontrib>XIAO FENG</creatorcontrib><creatorcontrib>ROZANNE LEE</creatorcontrib><creatorcontrib>JANE, SU QIAOJUAN</creatorcontrib><creatorcontrib>KATHY MANCHULENCHO</creatorcontrib><creatorcontrib>GIORGIO SENALDI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JASPAL, S. KANG</au><au>ORIT FOORD</au><au>JOHN, S. BABCOOK</au><au>CRAIG PIGOTT</au><au>MARY HAAK-FRENDSCHO</au><au>SCOTT KLAKAMP</au><au>LARRY GREEN</au><au>MEINA, L. LIANG</au><au>PALANISWAMI RATHANASWAMI</au><au>RAFFAELLA FAGGIONI</au><au>XIAO FENG</au><au>ROZANNE LEE</au><au>JANE, SU QIAOJUAN</au><au>KATHY MANCHULENCHO</au><au>GIORGIO SENALDI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF</title><date>2004-06-23</date><risdate>2004</risdate><abstract>Antibodies directed to the antigen TNFα and uses of such antibodies. In particular, fully human monoclonal antibodies directed to the antigen TNFα. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2003298816A1 |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JASPAL,%20S.%20KANG&rft.date=2004-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2003298816A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |